Chemical and Pharmacological Properties of Decoquinate: A Review of Its Pharmaceutical Potential and Future Perspectives
Open Access
- 30 June 2022
- journal article
- review article
- Published by MDPI AG in Pharmaceutics
- Vol. 14 (7) , 1383
Abstract
Decoquinate (DQ) is an antimicrobial agent commonly used as a feed additive for birds for human consumption. Its use as an additive is well established, but DQ has the potential for therapy as an antimicrobial drug for veterinary treatment and its optimized derivatives and/or formulations, mainly nanoformulations, have antimicrobial activity against pathogens that infect humans. However, DQ has a high partition coefficient and low solubility in aqueous fluids, and these biopharmaceutical properties have limited its use in humans. In this review, we highlight the antimicrobial activity and pharmacokinetic properties of DQ and highlight the solutions currently under investigation to overcome these drawbacks. A literature search was conducted focusing on the use of decoquinate against various infectious diseases in humans and animals. The search was conducted in several databases, including scientific and patent databases. Pharmaceutical nanotechnology and medicinal chemistry are the tools of choice to achieve human applications, and most of these applications have been able to improve the biopharmaceutical properties and pharmacokinetic profile of DQ. Based on the results presented here, DQ prototypes could be tested in clinical trials for human application in the coming years.Keywords
Funding Information
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Brasil (CAPES) (001)
This publication has 80 references indexed in Scilit:
- Formulation and Particle Size Reduction Improve Bioavailability of Poorly Water-Soluble Compounds with Antimalarial ActivityMalaria Research and Treatment, 2013
- Drug Screen Targeted at Plasmodium Liver Stages Identifies a Potent Multistage Antimalarial DrugThe Journal of Infectious Diseases, 2012
- Plasmodium vivax treatmentsCurrent Opinion in Infectious Diseases, 2011
- Targeting the Liver Stage of Malaria Parasites: A Yet Unmet GoalJournal of Medicinal Chemistry, 2011
- A Chemical Genomic Analysis of Decoquinate, a Plasmodium falciparum Cytochrome b InhibitorACS Chemical Biology, 2011
- Molecular basis of resistance to cytochromebc1inhibitorsFEMS Yeast Research, 2008
- Field study of the efficacy of halofuginone and decoquinate in the treatment of cryptosporidiosis in veal calvesVeterinary Record, 2006
- Analysis of the phenotypes in field populations ofEimeria acervulinaexpressing dual drug‐resistance to decoquinate and clopidolAvian Pathology, 1998
- Decoquinate and the control of experimental ovine toxoplasmosisVeterinary Record, 1996
- Studies of the mitochondria from Eimeria tenella and inhibition of the electron transport by quinolone coccidiostatsBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1975